Edge Therapeutics Inc Stock Nasdaq
Equities
US2798701098
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 275K | Capitalization | 140M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -63M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 510 x |
P/E ratio 2024 * |
-2.57
x | P/E ratio 2025 * |
-2.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Edge Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Director of Finance/CFO | 55 | Dec. 03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 19-04-01 |
Otis Brawley
BRD | Director/Board Member | 64 | 20-11-02 |
Richard Sykes
BRD | Director/Board Member | 79 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |